I think what we are beginning to see is that finishing the underway expansions is a given, but.... Nick and the BOD envision much more capacity needed to keep us ahead of the competition and the demand IS there. We are envisioning another plant on the east coast somewhere closer to some customers but still in the US. I totally agree.
My early background was in the underground coal industry and, eventually, I was buying reserves. I learned that if you had what was hard get (the rights to the coal in this case), the customers would gladly finance, in some way, all, or part of, the cost of starting a coal mine in exchange for long-term supply contracts.
So what is hard to get in our case? The expertise, a clean history of decades of superior products, premiere customer service, the good relationship with the FDA, EVERYTHING that a Pharmaceutical customer needs all the way through their clinical and commercial processing. So now, we not only have available cash to start a buildout somewhere, but we also have CDMO currency (shares) to pay for an acquisition or merger that would instantly or quickly give us capacity. Along with that, I have no doubt that major customers will agree to contribute financing for equipment that could be dedicated to their products.
The point is, we have the vision and we now have many options to expand and expand relatively quickly. I am very excited. Don't sell out until we get to that $84 or higher that none of us had dreamed of. Thank you Nick Green and our BOD!
Market Data 
Markets 
AI
